Five-year follow-up in patients after therapy stratification based on intracoronary pressure measurement

American Heart Journal

Volumn 153, Issue 3, 2007, Pages 403-409

  Rieber, Johannes ^a,b   Jung, Philip ^b   Koenig, Andreas ^b   Schiele, Thomas ^b   Shapiro, Michael ^a   Hoffmann, Udo ^a   Klauss, Volker ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33847260668     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.11.013     Document Type: Article

References (41)

1. Bech G.J., De Bruyne B., Pijls N.H., et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103 (2001) 2928-2934
2. Rieber J., Schiele T.M., Koenig A., et al. Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements. Am J Cardiol 90 (2002) 1160-1164
3. Mates M., Hrabos V., Hajek P., et al. Long-term follow-up after deferral of coronary intervention based on myocardial fractional flow reserve measurement. Coron Artery Dis 16 (2005) 169-174
4. Wijpkema J.S., Van der Vleuten P.A., Jessurun G.A., et al. Long-term safety of intracoronary haemodynamic assessment for deferral of angioplasty in intermediate coronary stenoses: a 5-year follow-up. Acta Cardiol 60 (2005) 207-211
5. Pijls NHJ. The DEFER study: 5 year follow-up. 14-4-2005. Unpublished Work.
6. Smith S.-C.J., Dove J.T., Jacobs A.K., et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37 (2001) 2215-2238
7. Campeau L. Letter: grading of angina pectoris. Circulation 54 (1976) 522-523
8. Hartigan P.M., Giacomini J.C., Folland E.D., et al. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. Am J Cardiol 82 (1998) 1445-1450
9. Hambrecht R., Walther C., Mobius-Winkler S., et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 109 (2004) 1371-1378
10. Parisi A.F., Hartigan P.M., and Folland E.D. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) Study. J Am Coll Cardiol 30 (1997) 1256-1263
11. Folland E.D., Hartigan P.M., and Parisi A.F. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators. J Am Coll Cardiol 29 (1997) 1505-1511
12. Hueb W.A., Bellotti G., de Oliveira S.A., et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 26 (1995) 1600-1605
13. Pitt B., Waters D., Brown W.V., et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 341 (1999) 70-76
14. Henderson R.A., Pocock S.J., Clayton T.C., et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42 (2003) 1161-1170
15. Zeymer U., Uebis R., Vogt A., et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation 108 (2003) 1324-1328
16. Hueb W., Soares P.R., Gersh B.J., et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43 (2004) 1743-1751
17. Parisi A.F., Folland E.D., and Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 326 (1992) 10-16
18. Dakik H.A., Kleiman N.S., Farmer J.A., et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 98 (1998) 2017-2023
19. Katritsis D.G., and Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 111 (2005) 2906-2912
20. Bech G.J., De Bruyne B., Bonnier H.J., et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 31 (1998) 841-847
21. Regar E., Serruys P.W., Bode C., et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 106 (2002) 1949-1956
22. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107 (2003) 381-383
23. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107 (2003) 24-27
24. Dangas G., Ellis S.G., Shlofmitz R., et al. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 45 (2005) 1186-1192
25. Babapulle M.N., Joseph L., Belisle P., et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
26. Ong A.T., McFadden E.P., Regar E., et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
27. Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
28. Ong A.T., Hoye A., Aoki J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
29. Virmani R., Farb A., Guagliumi G., et al. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 15 (2004) 313-318
30. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
31. Togni M., Windecker S., Cocchia R., et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46 (2005) 231-236
32. Valgimigli M., van Mieghem C.A., Ong A.T., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
33. De Bruyne B., Baudhuin T., Melin J.A., et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 89 (1994) 1013-1022
34. Pijls-Nico H.J., Van Gelder B., Van der Voort P., et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92 (1995) 3183-3193
35. Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996) 1703-1708
36. Bech G.J., Pijls N.H., De Bruyne B., et al. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 99 (1999) 883-888
37. Pijls N.H., Klauss V., Siebert U., et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 105 (2002) 2950-2954
38. Kern M.J., Donohue T.J., Aguirre F.V., et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 25 (1995) 178-187
39. Abe M., Tomiyama H., Yoshida H., et al. Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses: comparison with fractional flow reserve and coronary flow velocity reserve. Circulation 102 (2000) 2365-2370
40. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
41. Dawber T.R., Meadors G.F., and Moore Jr. F.E. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 41 (1951) 279-281